Daniel Hawkins’ surprise isn’t a matter of what, but when. The successful medtech executive and former Shockwave Medical CEO fully expected medical device makers would see Avail Medsystem’s telemedicine system as a more efficient way for sales reps to sit in on surgeries. By Hawkins’ projections, Avail’s system would eliminate much of the time sales […]
Shockwave ticks up on Street-beating Q2
Shockwave Medical (NSDQ:SWAV) shares got a slight boost today on second-quarter results that topped the consensus forecast. The Santa Clara, Calif.-based calcified coronary lesions treatment developer posted losses of -$18.1 million, or -56¢ per share, on sales of $10.3 million for the three months ended June 30, 2020, for a -70.8% bottom-line slide on sales growth […]
COVID-19 upends medtech’s financial outlook
The uncertain times brought on by the COVID-19 pandemic have affected businesses worldwide, and several sectors of medtech industry are projecting hits to their bottom lines. A number of companies have announced decisions to withdraw financial guidance, cut hours and/or staff, among other major business decisions. Initial impacts of the global pandemic on Wall Street […]
These young medtech companies raised the most money in 2019
Medical device industry insiders may very well remember 2019 as the year that IPOs came back — but another sign that the U.S. economy has left the Great Recession far behind. Among the top investment deals in the space, half involved public offerings, according to the MoneyTree report from PricewaterhouseCoopers (PwC) and CB Insights. Total investments […]
Shockwave Medical prices $75 million offering
Shockwave Medical (NSDQ:SWAV) filed a common stock equity offering with the SEC priced at $75 million. The Santa Clara, Calif.–based company said in yesterday’s filing that at the assumed public offering price of $36.14 that was reported on Nov. 11, it expects to offer nearly 2.1 million shares of common stock. Shockwave said it anticipates approximately […]
FDA grants Shockwave Medical breakthrough device label
Shockwave Medical (NSDQ:SWAV) has won breakthrough device designation from the FDA for the sonic pressure-wave system it has developed to treat calcified coronary lesions. The Santa Clara, Calif.-based company’s C2 IVL (intravascular lithotripsy) catheter is designed to improve blood flow to the heart by fracturing problematic calcium using sonic pressure waves to enable stent delivery, deployment […]
Abiomed’s stake in Shockwave is worth at least $58m
The $10 million Abiomed (NSDQ:ABMD) put into Shockwave Medical (NSDQ:SWAV) has paid off so far no matter how you slice it. Shockwave raised nearly $97 million in an initial public offering earlier this month, inking a private-placement deal with Abiomed on the side for $10.0 million worth of SWAV shares at the $17-per-share IPO price. […]
Abiomed adds $10m to $97m Shockwave IPO
Shockwave Medical this week raised nearly $97 million from its initial public offering and inked a private-placement deal with Abiomed (NSDQ:ABMD) for another $10 million. Santa Clara, Calif.-based Shockwave, which is developing a device to treat calcified coronary lesions with sonic pressure waves, said March 6 that it floated 5.7 million shares at $17 apiece, […]
Shockwave Medical sets terms for $75m IPO
Shockwave Medical this week set terms for its initial public offering, looking to bring in approximately $75 million, according to an SEC filing. The Santa Clara, Calif.-based company said that it plans to float approximately 5 million shares of its common stock at a price between $14 and $16, according to the filing. The IPO will […]
Shockwave Medical registers for $70m IPO
Shockwave Medical has registered for an upcoming initial public offering worth $70 million, according to recently posted SEC filings. The Santa Clara, Calif.-based vascular tech developer is looking to list its common stock on the Nasdaq Global Market under the symbol “SWAV,” according to the filing. Net proceeds from the offering are slated to support […]
Shockwave Medical launches U.S. pivotal for coronary lithotripsy
Shockwave Medical said today that it launched a U.S. pivotal trial for its coronary lithotripsy device, which is designed to prepare heavily calcified coronary lesions for stenting. The technology uses sonic pressure waves to fracture intimal and medial calcium without damaging arterial tissue, Santa Clara, Calif.-based Shockwave said. Last April the Shockwave S4 catheter, designed to similarly treat […]
